Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|August 28, 2012
Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical developmentShiro Soga, Shiro Akinaga, Yukimasa ShiotsuCurrent Cancer Drug Targets|October 8, 2003
Development of radicicol analoguesShiro Soga, Yukimasa Shiotsu, Shiro Akinaga, et al.The Journal of Antibiotics|January 19, 2017
The synthesis and evaluation of the antiproliferative activity of deacidified GEX1A analoguesTakamichi Imaizumi, Hiroshi Nakagawa, Ran Hori, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptideKenji Shibata, Toshiyuki Suzawa, Shiro Soga, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2008
Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in boneAkihiro Yano, Shinji Tsutsumi, Shiro Soga, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
New molecular and biological mechanism of antitumor activities of KW-2478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cellsTakayuki Nakashima, Toshihiko Ishii, Hisashi Tagaya, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activityHideyuki Onodera, Masami Kaneko, Yuichi Takahashi, et al.Bioorganic & Medicinal Chemistry|November 28, 2006
Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potentialRieko Tanaka, Almudena Rubio, Nancy K Harn, et al.Pageof 1